Ocean Biomedical, Inc. SEC filings OCEA
Ocean Biomedical, Inc. has 255 filings in SEC EDGAR's recent list, going back to Jul 19, 2021. Its latest annual report, Form 10-K, was filed on Apr 8, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 15, 2025, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Aug 5, 2025 (listing notice, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| 25-NSE | Delisting notice | Aug 8, 2025 | — |
| 8-K |
Current report
Listing notice, Officer or director change, Other events
|
Aug 5, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Agreement ended
|
Jul 16, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Agreement ended
|
Jun 13, 2025 | Jun 12, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change, Other events
|
Apr 23, 2025 | Apr 22, 2025 |
| 10-K | Annual report | Apr 8, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Apr 1, 2025 | Mar 28, 2025 |
| NT 10-K | Filing | Apr 1, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 26, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 20, 2025 | Mar 14, 2025 |
| DEFA14A | Additional proxy material | Mar 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Feb 26, 2025 | Feb 20, 2025 |
| DEF 14A | Proxy statement | Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 21, 2025 | Feb 21, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 14, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Feb 12, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 15, 2025 | Jan 7, 2025 |
| 10-Q | Quarterly report | Jan 13, 2025 | Sep 30, 2024 |
| 10-Q | Quarterly report | Dec 23, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Dec 23, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Auditor change
|
Dec 17, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Listing notice
|
Dec 11, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Listing notice
|
Dec 9, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Auditor change
|
Dec 6, 2024 | Dec 2, 2024 |
| 10-K | Annual report | Nov 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Nov 22, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 22, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 17, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 23, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 23, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
May 30, 2024 | May 22, 2024 |
| NT 10-Q | Filing | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Apr 24, 2024 | Apr 18, 2024 |
| 10-Q | Quarterly report | Apr 15, 2024 | Sep 30, 2023 |
| 10-Q/A | Amended quarterly report | Apr 15, 2024 | Jun 30, 2023 |
| 10-Q/A | Amended quarterly report | Apr 15, 2024 | Mar 31, 2023 |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2024 | Jan 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 26, 2024 | — |
| 8-K |
Current report
Listing notice
|
Jan 19, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 17, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Nov 30, 2023 | Nov 22, 2023 |
| 8-K |
Current report
Restatement
|
Nov 15, 2023 | Nov 10, 2023 |
| NT 10-Q | Filing | Nov 15, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Oct 12, 2023 | Oct 6, 2023 |
| 4 | Insider transaction | Oct 6, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 6, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 3, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 6, 2023 | Aug 30, 2023 |
| 424B3 | Prospectus | Aug 16, 2023 | — |
| 424B3 | Prospectus | Aug 16, 2023 | — |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| DEF 14A | Proxy statement | Aug 4, 2023 | Aug 4, 2023 |
| 424B3 | Prospectus | Aug 3, 2023 | — |
| PRE 14A | Preliminary proxy statement | Jul 24, 2023 | Jul 24, 2023 |
| EFFECT | Filing | Jul 7, 2023 | — |
| CORRESP | Letter to the SEC | Jul 6, 2023 | — |
| S-1/A | Amended registration statement | Jul 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2023 | — |
| 424B3 | Prospectus | Jun 23, 2023 | — |
| S-1 | Registration statement | Jun 22, 2023 | — |
| EFFECT | Filing | Jun 22, 2023 | — |
| CORRESP | Letter to the SEC | Jun 21, 2023 | — |
| CORRESP | Letter to the SEC | Jun 15, 2023 | — |
| S-1/A | Amended registration statement | Jun 15, 2023 | — |
| D | Filing | Jun 15, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2023 | — |
| 8-K |
Current report
Material agreement, New debt
|
Jun 8, 2023 | Jun 8, 2023 |
| CORRESP | Letter to the SEC | Jun 1, 2023 | — |
| S-1/A | Amended registration statement | Jun 1, 2023 | — |
| 8-K |
Current report
Material agreement
|
May 26, 2023 | May 25, 2023 |
| 10-Q | Quarterly report | May 24, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights
|
May 16, 2023 | May 15, 2023 |
| NT 10-Q | Filing | May 16, 2023 | Mar 31, 2023 |
| UPLOAD | Letter from the SEC | May 5, 2023 | — |
| S-1 | Registration statement | Apr 21, 2023 | — |
| 8-K/A | Amended current report | Mar 31, 2023 | Feb 14, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2023 | Mar 22, 2023 |
| 4 | Insider transaction | Mar 24, 2023 | Mar 22, 2023 |
| 4/A | Filing | Mar 24, 2023 | Feb 28, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2023 | Mar 16, 2023 |
| 4 | Insider transaction | Mar 2, 2023 | Feb 28, 2023 |
| 4 | Insider transaction | Mar 2, 2023 | Feb 28, 2023 |
| SC 13D | Ownership over 5% (active) | Feb 24, 2023 | — |
| SC 13D | Ownership over 5% (active) | Feb 24, 2023 | — |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 15, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 17, 2023 | Feb 14, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 17, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 17, 2023 | — |
| 8-K |
Current report
Material agreement
|
Feb 17, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 16, 2023 | Feb 14, 2023 |
| 3 | Initial insider ownership | Feb 16, 2023 | Feb 14, 2023 |
| 4 | Insider transaction | Feb 16, 2023 | Feb 14, 2023 |
| 25-NSE | Delisting notice | Feb 15, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 15, 2023 | Feb 14, 2023 |
| 8-K/A |
Amended current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
|
Feb 15, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
|
Feb 15, 2023 | Feb 14, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| 425 | Filing | Feb 13, 2023 | — |
| 8-K |
Current report
Material agreement
|
Feb 13, 2023 | Feb 10, 2023 |
| 425 | Filing | Feb 13, 2023 | — |
| 8-K |
Current report
Material agreement
|
Feb 13, 2023 | Feb 12, 2023 |
| 425 | Filing | Feb 13, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 13, 2023 | Feb 10, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| 425 | Filing | Feb 10, 2023 | — |
| 8-K |
Current report
Material agreement
|
Feb 10, 2023 | Feb 10, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2023 | — |
| 425 | Filing | Feb 9, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 9, 2023 | Feb 9, 2023 |
| 425 | Filing | Feb 8, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 8, 2023 | Feb 7, 2023 |
| 425 | Filing | Feb 7, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Feb 7, 2023 | Feb 3, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2023 | — |
| 425 | Filing | Feb 6, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 6, 2023 | Feb 3, 2023 |
| 425 | Filing | Feb 1, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 1, 2023 | Feb 1, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 31, 2023 | — |
| 425 | Filing | Jan 30, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 30, 2023 | Jan 30, 2023 |
| DEFR14A | Filing | Jan 25, 2023 | — |
| 425 | Filing | Jan 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 24, 2023 | Jan 24, 2023 |
| 425 | Filing | Jan 13, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2023 | Jan 12, 2023 |
| UPLOAD | Letter from the SEC | Jan 13, 2023 | — |
| DEF 14A | Proxy statement | Jan 12, 2023 | Jan 12, 2023 |
| PRER14A | Filing | Dec 30, 2022 | — |
| CORRESP | Letter to the SEC | Dec 30, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2022 | — |
| 425 | Filing | Dec 16, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2022 | Dec 15, 2022 |
| PRER14A | Filing | Dec 14, 2022 | — |
| CORRESP | Letter to the SEC | Dec 13, 2022 | — |
| 425 | Filing | Dec 13, 2022 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 13, 2022 | Dec 9, 2022 |
| 425 | Filing | Dec 8, 2022 | — |
| 8-K |
Current report
Material agreement
|
Dec 8, 2022 | Dec 5, 2022 |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| PRE 14A | Preliminary proxy statement | Nov 23, 2022 | Nov 23, 2022 |
| CORRESP | Letter to the SEC | Nov 22, 2022 | — |
| PRER14A | Filing | Nov 22, 2022 | — |
| PREM14A | Filing | Nov 22, 2022 | Nov 22, 2022 |
| 8-K |
Current report
Material agreement
|
Nov 21, 2022 | Nov 17, 2022 |
| PRER14A | Filing | Nov 18, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2022 | — |
| 425 | Filing | Nov 4, 2022 | — |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Nov 4, 2022 | Nov 4, 2022 |
| 425 | Filing | Nov 1, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 1, 2022 | Nov 1, 2022 |
| 425 | Filing | Nov 1, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 1, 2022 | Nov 1, 2022 |
| PRER14A | Filing | Oct 26, 2022 | — |
| CORRESP | Letter to the SEC | Oct 26, 2022 | — |
| 10-Q | Quarterly report | Oct 17, 2022 | Sep 30, 2022 |
| UPLOAD | Letter from the SEC | Oct 14, 2022 | — |
| 8-K |
Current report
Material agreement
|
Oct 5, 2022 | Oct 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 22, 2022 | Sep 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 19, 2022 | Sep 18, 2022 |
| PREM14A | Filing | Sep 16, 2022 | Sep 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 12, 2022 | Sep 12, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCEA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1869974
- Former names
- Ocean Biomedical, Inc./DE (until Feb 15, 2023); Aesther Healthcare Acquisition Corp. (until Feb 14, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.